Paper17877503
Epidemiology of hepatocellular carcinoma in Japan.
Umemura T and 1 other. Hepatol Res, 2007. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Epidemiology of hepatocellular carcinoma in Japan. Papers, record 17877503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17877503
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39273237 | Phase I-IV Drug Trials on Hepatocellular Carcinoma in Asian Populations: A Systematic Review of Ten Years of Studies. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273237 | PubMed |
| 26622825 | Clinicopathological characteristics of hepatitis B surface antigen-negative and hepatitis C antibody-negative hepatocellular carcinoma. | Oncol Lett | 2015 | https://conductscience.org/library/papers/26622825 | PubMed |
| 26475278 | Long-term prognosis after resection of cryptogenic hepatocellular carcinoma. | BMC Surg | 2015 | https://conductscience.org/library/papers/26475278 | PubMed |
| 26446004 | Efficacy of transcatheter arterial chemoembolization followed by sorafenib for intermediate/advanced hepatocellular carcinoma in patients in Japan: a retrospective analysis. | Clin Drug Investig | 2015 | https://conductscience.org/library/papers/26446004 | PubMed |
| 25252033 | Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular Carcinoma. | J Clin Lab Anal | 2015 | https://conductscience.org/library/papers/25252033 | PubMed |
| 25165471 | Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis. | Gastroenterol Res Pract | 2014 | https://conductscience.org/library/papers/25165471 | PubMed |
| 24510731 | Rare benign tumors of the liver: still rare? | J Gastrointest Cancer | 2014 | https://conductscience.org/library/papers/24510731 | PubMed |
| 24002762 | Surgical outcomes and clinical characteristics of elderly patients undergoing curative hepatectomy for hepatocellular carcinoma. | J Gastrointest Surg | 2013 | https://conductscience.org/library/papers/24002762 | PubMed |
| 23901350 | Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma. | J Cancer | 2013 | https://conductscience.org/library/papers/23901350 | PubMed |
| 23404391 | Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis C: report of a case. | Surg Today | 2014 | https://conductscience.org/library/papers/23404391 | PubMed |
| 23233864 | Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. | Hepat Mon | 2012 | https://conductscience.org/library/papers/23233864 | PubMed |
| 23092095 | Immunoregulation of hepatitis B virus infection--rationale and clinical application. | Nagoya J Med Sci | 2012 | https://conductscience.org/library/papers/23092095 | PubMed |
| 22977473 | Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma. | Exp Ther Med | 2011 | https://conductscience.org/library/papers/22977473 | PubMed |
| 22651810 | Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18). | Health Qual Life Outcomes | 2012 | https://conductscience.org/library/papers/22651810 | PubMed |
| 22563173 | Factors associated with the overall survival of elderly patients with hepatocellular carcinoma. | World J Gastroenterol | 2012 | https://conductscience.org/library/papers/22563173 | PubMed |
| 22320249 | Novel method to measure serum levels of des-gamma-carboxy prothrombin for hepatocellular carcinoma in patients taking warfarin: a preliminary report. | Cancer Sci | 2012 | https://conductscience.org/library/papers/22320249 | PubMed |
| 21484134 | Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma. | Hepatol Int | 2011 | https://conductscience.org/library/papers/21484134 | PubMed |
| 21278701 | The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area. | Med Sci Monit | 2011 | https://conductscience.org/library/papers/21278701 | PubMed |
| 21128329 | Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture. | World J Gastroenterol | 2010 | https://conductscience.org/library/papers/21128329 | PubMed |
| 19148802 | Epidemiology of hepatocellular carcinoma in Japan. | J Gastroenterol | 2009 | https://conductscience.org/library/papers/19148802 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17877503
GET https://conductscience.org/api/papers/v1/17877503/cited_by?page=2